Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Trinity Bio ADR (TRIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 142,734
  • Shares Outstanding, K 23,710
  • Annual Sales, $ 99,610 K
  • Annual Income, $ -100,630 K
  • 36-Month Beta 1.30
  • Price/Sales 1.46
  • Price/Cash Flow 12.87
  • Price/Book 1.33

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.50 +10.55%
on 07/11/17
6.13 -0.82%
on 06/26/17
+0.25 (+4.29%)
since 06/23/17
3-Month
5.24 +16.03%
on 05/18/17
6.21 -2.09%
on 04/28/17
+0.60 (+10.95%)
since 04/24/17
52-Week
5.20 +16.92%
on 03/14/17
13.68 -55.56%
on 08/29/16
-6.32 (-50.97%)
since 07/22/16

Most Recent Stories

More News
Trinity Biotech Announces Results for Q2, 2017

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June...

TRIB : 6.08 (+1.00%)
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2017 Financial Results

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter...

TRIB : 6.08 (+1.00%)
Global Anti-nuclear Antibody (ANA) Testing Market 2017-2021 - Key vendors are Abbott Laboratories, Alere, Bio-Rad Laboratories & Thermo Fisher Scientifi

Research and Markets has announced the addition of the "Global Anti-nuclear Antibody (ANA) Testing Market 2017-2021" report to their offering. The analysts forecast the global anti-nuclear antibody (ANA)...

TRIB : 6.08 (+1.00%)
ABT : 50.80 (-0.08%)
Harwood Feffer LLP Announces Investigation of Trinity Biotech plc

Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against officers and directors of Trinity Biotech plc ("Trinity" or the "Company") (NASDAQ: TRIB).

TRIB : 6.08 (+1.00%)
Trinity Biotech Announces Results for Q1, 2017

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March...

TRIB : 6.08 (+1.00%)
Trinity Biotech plc to Announce First Quarter Fiscal Year 2017 Financial Results

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter...

TRIB : 6.08 (+1.00%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Trinity Biotech plc (TRIB)

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Trinity Biotech plc ("Trinity" or the "Company") (NASDAQ: TRIB). Such investors are...

TRIB : 6.08 (+1.00%)
INVESTOR ALERT: Glancy Prongay & Murray Commences Investigation on Behalf of Trinity Biotech plc Investors

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of investors of Trinity Biotech plc ("Trinity" or the "Company") (NASDAQ: TRIB) concerning the Company...

TRIB : 6.08 (+1.00%)
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2016 Financial Results

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter...

TRIB : 6.08 (+1.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and...

See More

Support & Resistance

2nd Resistance Point 6.26
1st Resistance Point 6.17
Last Price 6.08
1st Support Level 5.92
2nd Support Level 5.77

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.